Loading clinical trials...
Loading clinical trials...
Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers: a Double-blind, Randomised, Placebo-controlled, Crossover Study Within the Shift2Health Project
Conditions
Interventions
Verum (A)
Placebo (B)
Locations
1
Austria
FH JOANNEUM University of Applied Sciences
Graz, Styria, Austria
Start Date
January 20, 2026
Primary Completion Date
October 1, 2027
Completion Date
February 1, 2028
Last Updated
February 27, 2026
NCT07244458
NCT07457437
NCT07225426
NCT07423780
NCT07430007
NCT07414043
Lead Sponsor
FH Joanneum Gesellschaft mbH
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions